Ventricular fibrillation in MYH7-related hypertrophic cardiomyopathy before onset of ventricular hypertrophy

Heart Rhythm

Volumn 6, Issue 9, 2009, Pages 1366-1369

  Christiaans, Imke ^a   Lekanne dit Deprez, Ronald H ^a   van Langen, Irene M ^a   Wilde, Arthur A M ^a  

^a UNIVERSITY OF AMSTERDAM   (Netherlands)

Author keywords

Genetics; Hypertrophic cardiomyopathy; Hypertrophy; Sudden cardiac death; Ventricular fibrillation

Indexed keywords

ARGININE; CREATINE KINASE; CREATINE KINASE MB; LEUCINE; METHOXY ISOBUTYL ISONITRILE TECHNETIUM TC 99M; MYOSIN BINDING PROTEIN C; MYOSIN BINDING PROTEIN C3; MYOSIN HEAVY CHAIN BETA; TROPONIN T; TROPONIN T2; UNCLASSIFIED DRUG; CARDIAC MYOSIN; MYH7 PROTEIN, HUMAN; MYOSIN HEAVY CHAIN;

ADULT; ANGIOCARDIOGRAPHY; ARTICLE; CASE REPORT; COLLAPSE; CONVALESCENCE; CREATINE KINASE BLOOD LEVEL; DEFIBRILLATION; DEFIBRILLATOR; ECHOCARDIOGRAPHY; ELECTROCARDIOGRAPHY; EXERCISE TEST; EXTUBATION; FEMALE; FOLLOW UP; GENERAL PRACTITIONER; GENETIC ANALYSIS; HEART ATRIUM ENLARGEMENT; HEART CATHETERIZATION; HEART ELECTROPHYSIOLOGY; HEART FAILURE; HEART LEFT VENTRICLE FUNCTION; HEART REPOLARIZATION; HEART SCINTISCANNING; HEART VENTRICLE FIBRILLATION; HEART VENTRICLE HYPERTROPHY; HUMAN; HYPERTROPHIC CARDIOMYOPATHY; HYPERVENTILATION; MISSENSE MUTATION; MOLECULAR GENETICS; MOTHER; PRIORITY JOURNAL; Q WAVE; RESUSCITATION; SINUS RHYTHM; SINUS TACHYCARDIA; COMPLICATION; DEATH, SUDDEN, CARDIAC; GENETICS; HYPERTROPHY, LEFT VENTRICULAR; IMPLANTABLE CARDIOVERTER DEFIBRILLATOR; PATHOPHYSIOLOGY; RISK FACTOR; TIME; VENTRICULAR FIBRILLATION;

ADULT; CARDIAC MYOSINS; CARDIOMYOPATHY, HYPERTROPHIC; DEATH, SUDDEN, CARDIAC; DEFIBRILLATORS, IMPLANTABLE; ELECTROCARDIOGRAPHY; FEMALE; HUMANS; HYPERTROPHY, LEFT VENTRICULAR; MYOSIN HEAVY CHAINS; RISK FACTORS; TIME FACTORS; VENTRICULAR FIBRILLATION;

EID: 69049087629     PISSN: 15475271     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.hrthm.2009.04.029     Document Type: Article

References (18)

1. Maron B.J., Gardin J.M., Flack J.M., et al. Prevalence of hypertrophic cardiomyopathy in a general population of young adults. Echocardiographic analysis of 4111 subjects in the CARDIA Study. Coronary Artery Risk Development in (Young) Adults. Circulation 92 (1995) 785-789
2. Elliott P., Andersson B., Arbustini E., et al. Classification of the cardiomyopathies: a position statement from the European Society Of Cardiology Working Group on Myocardial and Pericardial Diseases. Eur Heart J 29 (2008) 270-276
3. Maron B.J., Towbin J.A., Thiene G., et al. Contemporary definitions and classification of the cardiomyopathies: an American Heart Association Scientific Statement from the Council on Clinical Cardiology, Heart Failure and Transplantation Committee; Quality of Care and Outcomes Research and Functional Genomics and Translational Biology Interdisciplinary Working Groups; and Council on Epidemiology and Prevention. Circulation 113 (2006) 1807-1816
4. Elliott P.M., Gimeno J.R., Thaman R., et al. Historical trends in reported survival rates in patients with hypertrophic cardiomyopathy. Heart 92 (2006) 785-791
5. Maron B.J., McKenna W.J., Danielson G.K., et al. American College of Cardiology/European Society of Cardiology clinical expert consensus document on hypertrophic cardiomyopathy. A report of the American College of Cardiology Foundation Task Force on Clinical Expert Consensus Documents and the European Society of Cardiology Committee for Practice Guidelines. J Am Coll Cardiol 42 (2003) 1687-1713
6. Maron B.J., Kragel A.H., and Roberts W.C. Sudden death in hypertrophic cardiomyopathy with normal left ventricular mass. Br Heart J 63 (1990) 308-310
7. McKenna W.J., Stewart J.T., Nihoyannopoulos P., et al. Hypertrophic cardiomyopathy without hypertrophy: two families with myocardial disarray in the absence of increased myocardial mass. Br Heart J 63 (1990) 287-290
8. Moolman J.S., Corfield V.A., Posen B., et al. Sudden death due to troponin T mutations. J Am Coll Cardiol 29 (1997) 549-555
9. Richard P., Charron P., Carrier L., et al. Hypertrophic cardiomyopathy: distribution of disease genes, spectrum of mutations, and implications for a molecular diagnosis strategy. Circulation 107 (2003) 2227-2232
10. Van Driest S.L., Jaeger M.A., Ommen S.R., et al. Comprehensive analysis of the beta-myosin heavy chain gene in 389 unrelated patients with hypertrophic cardiomyopathy. J Am Coll Cardiol 44 (2004) 602-610
11. Charron P., Dubourg O., Desnos M., et al. Clinical features and prognostic implications of familial hypertrophic cardiomyopathy related to the cardiac myosin-binding protein C gene. Circulation 97 (1998) 2230-2236
12. Niimura H., Bachinski L.L., Sangwatanaroj S., et al. Mutations in the gene for cardiac myosin-binding protein C and late-onset familial hypertrophic cardiomyopathy. N Engl J Med 338 (1998) 1248-1257
13. Charron P., Dubourg O., Desnos M., et al. Genotype-phenotype correlations in familial hypertrophic cardiomyopathy. a comparison between mutations in the cardiac protein-C and the beta-myosin heavy chain genes. Eur Heart J 19 (1998) 139-145
14. Van Driest S.L., Vasile V.C., Ommen S.R., et al. Myosin binding protein C mutations and compound heterozygosity in hypertrophic cardiomyopathy. J Am Coll Cardiol 44 (2004) 1903-1910
15. Van Driest S.L., Ommen S.R., Tajik A.J., et al. Sarcomeric genotyping in hypertrophic cardiomyopathy. Mayo Clin Proc 80 (2005) 463-469
16. Nanni L., Pieroni M., Chimenti C., et al. Hypertrophic cardiomyopathy: two homozygous cases with "typical" hypertrophic cardiomyopathy and three new mutations in cases with progression to dilated cardiomyopathy. Biochem Biophys Res Commun 309 (2003) 391-398
17. Rayment I., Holden H.M., Sellers J.R., et al. Structural interpretation of the mutations in the beta-cardiac myosin that have been implicated in familial hypertrophic cardiomyopathy. Proc Natl Acad Sci U S A 92 (1995) 3864-3868
18. Song L., Zou Y., Wang J., et al. Mutations profile in Chinese patients with hypertrophic cardiomyopathy. Clin Chim Acta 351 (2005) 209-216